Free Trial

SPDR S&P Biotech ETF Rating

SPDR S&P Biotech ETF logo
$104.99 -1.53 (-1.44%)
Closing price 10/10/2025 04:10 PM Eastern
Extended Trading
$104.48 -0.51 (-0.49%)
As of 10/10/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

XBI Aggregate Rating

Moderate Buy
2.65

Holdings in XBI have an aggregate rating of Moderate Buy based on 513 analyst ratings issued in the past year covering 25 companies (46.3% of the portfolio).

XBI Aggregate Price Target

$104.99
High Prediction$104.99
Average Prediction$104.99
Low Prediction$104.99

Holdings in XBI have an aggregate price target of $104.99 and a range of $104.99 to $104.99 covering 25 companies (46.3% of the portfolio).

XBI Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
Moderate Buy
19 Moderate Buy rating(s)
Hold
6 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by SPDR S&P Biotech ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 25 XBI Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
2.48%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$73.07
-2.5%
1.6614 of 5 stars
2.42$71.50 -2.1%19News Coverage
Analyst Forecast
2.07%
Moderna, Inc. stock logo
MRNA
Moderna
$26.83
-2.5%
4.2253 of 5 stars
2.00$41.81 55.8%23Analyst Forecast
1.99%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$440.00
-1.2%
4.1986 of 5 stars
2.67$457.21 3.9%15Analyst Forecast
Insider Trade
1.99%
AbbVie Inc. stock logo
ABBV
AbbVie
$230.88
+0.1%
4.5794 of 5 stars
2.79$231.90 0.4%28Positive News
Analyst Forecast
Analyst Revision
1.95%
Exelixis, Inc. stock logo
EXEL
Exelixis
$38.15
-1.1%
4.8255 of 5 stars
2.63$44.42 16.4%24Trending News
Analyst Forecast
Analyst Revision
1.93%
Biogen Inc. stock logo
BIIB
Biogen
$146.57
-2.0%
4.6028 of 5 stars
2.32$180.15 22.9%31Trending News
Analyst Forecast
Analyst Revision
1.92%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$564.63
-0.9%
4.7293 of 5 stars
2.79$817.46 44.8%29Trending News
Analyst Forecast
Analyst Revision
1.90%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$69.97
-0.4%
3.4595 of 5 stars
2.80$78.28 11.9%20Trending News
Analyst Forecast
Insider Trade
1.90%
Amgen Inc. stock logo
AMGN
Amgen
$290.13
-1.8%
4.5468 of 5 stars
2.35$309.42 6.6%20Positive News
Analyst Upgrade
Analyst Revision
1.87%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$407.79
-1.7%
4.8292 of 5 stars
2.62$494.38 21.2%29Positive News
Analyst Forecast
Analyst Revision
1.86%
Insmed, Inc. stock logo
INSM
Insmed
$162.33
-1.3%
3.02 of 5 stars
2.86$149.06 -8.2%21Analyst Forecast
1.86%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$429.60
+0.3%
4.3596 of 5 stars
2.73$525.88 22.4%11News Coverage
Analyst Forecast
1.82%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$58.34
-1.9%
4.4164 of 5 stars
2.92$69.19 18.6%24Trending News
Analyst Forecast
Insider Trade
1.81%
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$52.32
-2.8%
4.8929 of 5 stars
2.55$93.26 78.3%22Trending News
Analyst Forecast
Analyst Revision
1.81%
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$48.24
+1.3%
4.0625 of 5 stars
2.93$74.64 54.7%15Analyst Forecast
1.79%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$55.49
+1.3%
4.0573 of 5 stars
2.89$63.94 15.2%18Analyst Forecast
Insider Trade
1.78%
Incyte Corporation stock logo
INCY
Incyte
$83.80
-1.1%
4.3754 of 5 stars
2.22$84.79 1.2%18Analyst Forecast
1.75%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$459.66
+0.6%
3.9547 of 5 stars
2.82$457.16 -0.5%28Analyst Forecast
1.72%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$136.63
-1.3%
4.7633 of 5 stars
2.80$163.44 19.6%20Analyst Forecast
1.72%
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$33.76
-3.5%
4.4339 of 5 stars
2.67$49.00 45.1%6Analyst Forecast
Analyst Revision
1.71%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$117.18
+0.4%
4.8791 of 5 stars
2.86$118.08 0.8%29Trending News
Analyst Forecast
Analyst Revision
1.69%
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$49.77
-2.0%
1.9451 of 5 stars
2.95$68.32 37.3%20Analyst Forecast
Insider Trade
1.68%
Natera, Inc. stock logo
NTRA
Natera
$169.27
-2.2%
2.8366 of 5 stars
2.90$192.88 13.9%20Analyst Forecast
1.68%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$64.10
-1.6%
4.693 of 5 stars
2.31$70.44 9.9%13Trending News
Analyst Upgrade
Analyst Revision
1.65%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$16.04
-0.5%
3.4089 of 5 stars
2.80$19.94 24.3%10Analyst Forecast
Insider Trade

This page (NYSEARCA:XBI) was last updated on 10/12/2025 by MarketBeat.com Staff
From Our Partners